Colon cancer used to feel like a worry for later-something to think about decades down the road. Not anymore. An estimated ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

They told me it was effective, and I knew mailing a Cologuard box back would be pretty dang easy.” Cologuard — a simple way ...

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home ...

Squeamish about your upcoming colonoscopy? A new technology may change the way doctors can look for colon cancer, and it may provide an alternative to this procedure. A procedure that looks for cancer ...

As of July 1, Ontarians age 45 and up are eligible to receive the at-home fecal immunochemical screening test — or FIT — that ...

Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a ...

A major European trial has pushed colonoscopy back into the medical spotlight. After 13 years, the NordICC study found that one invitation to colonoscopy reduced new colorectal cancer diagnoses, but ...

Colorectal cancer is now the leading cause of cancer-related death among adults under 50 in the United States, and diagnoses in younger adults continue to increase at an alarming rate. In fact, it has ...